To include your compound in the COVID-19 Resource Center, submit it here.

Elan 3Q revenue guidance

ELN said after market close it expects third quarter sales of $200 million - $175 million less than the $375 million

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE